Skip to content
OpenCapital
Get started

AMN Healthcare AMN Effect of dilutive RSUs and PSUs (in shares)

Effect of dilutive RSUs and PSUs (in shares) at other companies

Avanos Medical logo
Avanos MedicalAVNS
1M+42.9%

Other financials

Income statement

See full
Revenue$1.4B+99.9%
Gross profit$368.8M+86.2%
Operating income$117.2M+837%
Net income$62.2M+5,793%
EPS (diluted)$1.59+5,400%

Balance sheet

See full
Cash & equivalents$595.0M+528%
Total debt$776.9M-12.4%
Total equity$712.8M-0.3%
Total assets$2.6B+8.7%

Cash flow

See full
Operating cash flow$562.5M+507%
CapEx$7.2M-27.4%
Free cash flow$555.2M+571%

Valuation

See full
Market cap$1.23B+47.0%
Enterprise value$1.41B-13.3%
P/S0.4×+0.1×

Profitability

See full
Gross margin27.6%-2.5pp
Operating margin-9.8%-14.2pp
Net margin-0.9%-0.4pp
FCF margin20.7%+11.6pp

Returns & leverage

See full
Return on equity-4.5%-2.0pp
Debt / equity1.1×-0.2×
Current ratio1.1×0.0×

Where this comes from

Reported directly by AMN Healthcare in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment.

The official record: AMN Healthcare’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about AMN Healthcare's effect of dilutive rsus and psus (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AMN Healthcare's effect of dilutive rsus and psus (in shares)?
AMN Healthcare (AMN) reported effect of dilutive rsus and psus (in shares) of $216K in Q1 2026.
What is the long-term trend for AMN Healthcare's effect of dilutive rsus and psus (in shares)?
Over 3 years (2021 to 2025), AMN Healthcare's effect of dilutive rsus and psus (in shares) has grown at a -58.3% compound annual growth rate (CAGR), from $1.02M to $74K.